(Q28568147)

31 January 2017

title

Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment (English)

1 reference

31 January 2017

0 references

J. Marksteiner

1

1 reference

31 January 2017

U. Weiss

2

1 reference

31 January 2017

C. Weis

3

1 reference

31 January 2017

A. Laslop

4

1 reference

31 January 2017

R. Fischer-Colbrie

5

1 reference

31 January 2017

C. Humpel

6

1 reference

31 January 2017

J. Feldon

7

1 reference

31 January 2017

W. W. Fleischhacker

8

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

31 January 2017

1 reference

31 January 2017

volume

104

1 reference

31 January 2017

issue

2

1 reference

31 January 2017

page(s)

325–333

1 reference

Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study

31 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Regulation of the biosynthesis and processing of chromogranins in organotypic slices: influence of depolarization, forskolin and differentiating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Posttranslational processing of proenkephalins and chromogranins/secretogranins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Cell-free and cellular synthesis of chromogranin A and B of bovine adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The primary structure of rat secretogranin II deduced from a cDNA sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Regulated secretion. Helper proteins for neuroendocrine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Primary structure of rat chromogranin A and distribution of its mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Chromogranin A: current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Secretoneurin and chemoattractant receptor interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Neuroendocrine cell type-specific and inducible expression of the secretogranin II gene: crucial role of cyclic adenosine monophosphate and serum response elements

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

PE-11, a peptide derived from chromogranin B, in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain: an immunocytochemical and radioimmunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Effects of phencyclidine on immediate early gene expression in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Phencyclidine alters regional concentrations of neuropeptide Y and peptide YY in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C).

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The reduced neuropil hypothesis: a circuit based model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Differential increases in chromogranins, but not synapsin I, in cortical neurons following spreading depression: implications for functional roles and transmitter peptide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Receptor mechanisms in antipsychotic drug action: focus on sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Behavioral effects of chronic phencyclidine administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The disulfide-bonded loop of chromogranins, which is essential for sorting to secretory granules, mediates homodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

The chromogranins A and B: the first 25 years and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4522%2801%2900081-1

7 January 2021

10.1016/S0306-4522(01)00081-1

Identifiers

DOI

0 references

1 reference